Advisor Group Holdings, Inc. Exagen Inc. Transaction History

Advisor Group Holdings, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$2.23 - $2.9 $80 - $104	-36 Reduced 5.25%	650 $1,000
Q4 2022 Feb 10, 2023	SELL	$2.1 - $3.4 $9,496 - $15,374	-4,522 Reduced 86.83%	686 $1,000
Q3 2022 Nov 14, 2022	SELL	$3.43 - $8.68 $164 - $416	-48 Reduced 0.91%	5,208 $14,000
Q2 2022 Aug 10, 2022	BUY	$4.18 - $7.74 $1,262 - $2,337	302 Added 6.1%	5,256 $31,000
Q1 2022 May 04, 2022	BUY	$7.12 - $11.06 $2,691 - $4,180	378 Added 8.26%	4,954 $39,000

Q3 2021 Nov 05, 2021	BUY	$10.25 - $15.21 $1,250 - $1,855	122 Added 2.74%	4,576 $62,000
Q2 2021 Aug 02, 2021	BUY	$12.4 - $17.92 $11,246 - $16,253	907 Added 25.57%	4,454 $66,000
Q1 2021 May 13, 2021	BUY	$13.9 - $22.0 $49,303 - $78,034	3,547 New	3,547 $63,000

6.21M

1.6K

4.1K

Ticker XGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,260,400
Market Cap $28.9M
Description
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.